摘要
蛋白激酶C(PKC)是一类由多种同工酶组成的丝氨酸 /苏氨酸蛋白激酶家族。高血糖和游离脂肪酸 (FFA)可影响信号传导通路 ,特别是激活二酰甘油 (DG) PKC途径 ,PKC的激活可引起胰岛素抵抗 (IR)及糖尿病血管并发症。PKC β选择性抑制剂 (LY 3335 31)
Protein kinase C(PKC) is a serine/threonine kinase groups including a series of isoenzyme.Hyperglycemia and elevated free fatty acid can affect signal transduction pathway function,in particular activation of diacylglycerol (DG) and PKC,which occurs in the diabetic state. Activation of PKC lead to insulin resistance and diabetic vascular complications. PKC β isoform selective inhibitor(LY 333531) and vitamin E have shown potential effect as therapies for diabetic vascular complication.
出处
《医学研究生学报》
CAS
2003年第9期708-709,713,共3页
Journal of Medical Postgraduates
关键词
蛋白激酶C
胰岛素抵抗
糖尿病血管并发症
Protein kinase C
Insulin resistance
Diabetic vascular complication